M
Marco Durante
Researcher at Technische Universität Darmstadt
Publications - 495
Citations - 16100
Marco Durante is an academic researcher from Technische Universität Darmstadt. The author has contributed to research in topics: Particle therapy & Relative biological effectiveness. The author has an hindex of 57, co-authored 449 publications receiving 13453 citations. Previous affiliations of Marco Durante include International Institute of Minnesota & University of Trento.
Papers
More filters
Journal ArticleDOI
Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings
TL;DR: A review of the new results in this specialty will be presented here, and an increased understanding of the oncogenic potential of galactic cosmic rays is focussed on.
Journal ArticleDOI
Charged particles in radiation oncology
Marco Durante,Jay S. Loeffler +1 more
TL;DR: In this paper, a review of particle therapy in radiotherapy is presented, and the authors identify and discuss the research questions that have resulted with this technique, and conclude that the high costs of accelerators and beam delivery in particle therapy are justified by a clear clinical advantage.
Journal ArticleDOI
Heavy ion carcinogenesis and human space exploration
TL;DR: Here, it is described how research in cancer radiobiology can support human missions to Mars and other planets.
Journal ArticleDOI
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.
Tadashi Kamada,Hirohiko Tsujii,Eleanor A. Blakely,Jürgen Debus,Wilfried De Neve,Marco Durante,Oliver Jäkel,Ramona Mayer,Roberto Orecchia,Richard Pötter,S. Vatnitsky,William T. Chu +11 more
TL;DR: A panel of radiation oncologists, radiobiologists, and medical physicists from the USA and Europe recently completed peer review of the carbon ion therapy at NIRS, and promising data were obtained for other tumours, such as locally recurrent rectal cancer and pancreatic cancer.
Journal ArticleDOI
Charged particle therapy--optimization, challenges and future directions.
Jay S. Loeffler,Marco Durante +1 more
TL;DR: Charged particles can potentially replace surgery for radical cancer treatments, which might be beneficial as the success of surgical cancer treatments are largely dependent on the expertise and experience of the surgeon and the location of the tumour.